Imprivata will unlock further value for customers by unifying, integrating, and automating digital identity to enable autonomous identity systems

Integration of Verosint Identity Threat Detection & Response with Imprivata Enterprise Access Management will strengthen the company’s advanced and passwordless access strategy to bolster security, improve workflow efficiency, and drive ROI at enterprise scale

Last week, Frost and Sullivan named Imprivata the recipient of the 2012 North American Customer Value Enhancement Award in Healthcare. For this award, Frost and Sullivan analysts apply their 360-Degree Perspective™ taking into account all aspects of a company’s business from market drivers, customer value, industry partnerships, return on investment for the solution and overall financial stability of the organization.

Enterprise-class PAM solution bolsters Imprivata’s identity and access management platform for enterprise organizations in healthcare and beyond

Thoma Bravo to pay $19.25 per share, representing a 33% premium to Imprivata’s stock price

Transaction valued at approximately $544 million

Company Recognized for Market Leadership, Pioneering Technology and Broad Customer Base